Skip to main content

Animations

MJFF Publications

6471 - 6480 of 8587 Results
Title
Year
  • Year
  • 2019
  • 2021
  • 2020
  • 2019
  • 2024
  • 2020
  • 2019
  • 2025
  • 2017
  • 2005
  • Summary Details
    OPEN
    Title: Generation of human midbrain organoids from induced pluripotent stem cells
    Journal Name: MNI Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.12688/mniopenres.12816.1
    Citation Count: 12
  • Summary Details
    OPEN
    Title: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During Aging
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2021.721749
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
    Journal Name: BMC Research Notes
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13104-020-04994-7
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advances
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00716-z
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00362-y
    Citation Count: 79
  • Summary Details
    OPEN
    Title: ARSA variants in α-synucleinopathies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz340
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf066
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Targeted deletion ofGD3synthase protects againstMPTP‐induced neurodegeneration
    Journal Name: Genes, Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain
    DOI - Digital Object Identifier: 10.1111/gbb.12377
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Parkin-deficient mice are not a robust model of parkinsonism
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0409598102
    Citation Count: 462
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.